期刊文献+

心力衰竭的病理生理研究进展 被引量:6

Progress on Pathologic and Physiological Function of Heart Failure
下载PDF
导出
摘要 心力衰竭是心脏疾病的终末阶段,其特征是心脏收缩舒张功能紊乱,心脏排血量不足,并且伴随着一系列的并发症状。近年来,国内外深入地研究了引起犬发生心力衰竭的各种病理机制。这些机制主要包括内皮素系统、一氧化氮、Ca2+、肾上腺及其受体和肾素-血管紧张素系统的病理生理作用,以及在发生心力衰竭时的心肌细胞及细胞外基质的病理变化。详细地了解这些发病机制,可为临床上更好的治疗心力衰竭以及选择合适的治疗药物提供理论依据。 Heart failure is the final period of heart diseases, which is characterized by function disorder of heart contract-stretch, deficiency of blood ejection, and with a series of symdromes. The pathologic mechanisms had been studied deeply these years. This article referred to literatures of home and abroad, summarized the pathologic mechanism of heart failure in detail. This mechanism involved pathologic and physiologic effect of Endothelin system,NO. Ca^2+ . adrenalin and hypertension.the pathologic changes of cardiac muscle cell with heart failure happening. Studying the mechanism intensively is to treat heart failure effectively and select suitable drugs.
出处 《动物医学进展》 CSCD 2005年第9期17-21,共5页 Progress In Veterinary Medicine
关键词 心力衰竭 病理机制 heart failure pathologic mechanism
  • 相关文献

参考文献25

  • 1Becker R,Merkely B,Bauer A,et al.Ventricular arrhythmias induced by endothelin-1 or by acute ischemia: a comparative analysis using three-dimensional mapping[J]. Cardiovascular Research, 2000,45(2):310-320.
  • 2Antonio M,Aguilara A,Reverta F,et al.Ntravenous BQ-123 and phosphoramidon reduce ventricular ectopic beats and myocardial infarct size in dogs submitted to coronary occlusion and reperfusion[J]. General Pharmacology, 2000,35(3):143-147.
  • 3Wang X W, Masato O,Atsuyuki W, et al. Endothelin-1 promotes vascular structural remodeling during the progression of heart failure: Prevention of vascular remodeling using a specific endothelin-converting enzyme inhibitor[J]. Life Science ,2001, 69(21):2477-2488.
  • 4Nakamura R, Egashira K, Arimura K,et al.Increased inactivation of nitric oxide is involved in impaired coronary flow reserve in heart failure[J]. Am J Physiol Heart Circ Physiol, 2001 ,281(6):2619-2625.
  • 5Arimura K, Egashira K, Nakamura R,et al. Increased inactivation of nitric oxide is involved in coronary endothelial dysfunction in heart failure[J]. Am J Physiol Heart Circ Physiol,2001,280(1):68-75.
  • 6Zhang X P, Tada H, Wang Z,et al. cAMP signal transduction, a potential compensatory pathway for coronary endothelial NO production after heart failure[J]. Arterioscler Thromb Vasc Biol,2002,22(8):1273-1278.
  • 7Chen Y, Traverse J H, Du R,et al.Nitric oxide modulates myocardial oxygen consumption in the failing heart[J].Circulation, 2002,106(2):273-279.
  • 8Traverse J H, Chen Y, Hou M,et al.Inhibition of NO production increases myocardial blood flow and oxygen consumption in congestive heart failure[J]. Am J Physiol Heart Circ Physiol,2002 ,282(6):2278-2283.
  • 9Hobai I A, O'Rourke B.Enhanced Ca(2+)-activated Na(+)-Ca(2+) exchange activity in canine pacing-induced heart failure[J].Circ Res, 2000 ,87(8):690-698.
  • 10Jiang M T, Lokuta A J, Farrell E F,et al.Abnormal Ca^2+release, but normal ryanodine receptors, in canine and human heart failure[J]. Circ Res,2000, 91(11):979-981.

同被引文献79

引证文献6

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部